442 related articles for article (PubMed ID: 35163166)
1. Estrogen Receptors-Mediated Apoptosis in Hormone-Dependent Cancers.
Chimento A; De Luca A; Avena P; De Amicis F; Casaburi I; Sirianni R; Pezzi V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163166
[TBL] [Abstract][Full Text] [Related]
2. Single-chain estrogen receptors (ERs) reveal that the ERalpha/beta heterodimer emulates functions of the ERalpha dimer in genomic estrogen signaling pathways.
Li X; Huang J; Yi P; Bambara RA; Hilf R; Muyan M
Mol Cell Biol; 2004 Sep; 24(17):7681-94. PubMed ID: 15314175
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
Kabos P; Finlay-Schultz J; Li C; Kline E; Finlayson C; Wisell J; Manuel CA; Edgerton SM; Harrell JC; Elias A; Sartorius CA
Breast Cancer Res Treat; 2012 Sep; 135(2):415-32. PubMed ID: 22821401
[TBL] [Abstract][Full Text] [Related]
5. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
Fan M; Bigsby RM; Nephew KP
Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
[TBL] [Abstract][Full Text] [Related]
6. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
7. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
Woodfield GW; Horan AD; Chen Y; Weigel RJ
Cancer Res; 2007 Sep; 67(18):8439-43. PubMed ID: 17875680
[TBL] [Abstract][Full Text] [Related]
8. Regulation of cell growth by estrogen signaling and potential targets in thyroid cancer.
Chen GG; Vlantis AC; Zeng Q; van Hasselt CA
Curr Cancer Drug Targets; 2008 Aug; 8(5):367-77. PubMed ID: 18690843
[TBL] [Abstract][Full Text] [Related]
9. Molecular action of the estrogen receptor and hormone dependency in breast cancer.
Iwase H
Breast Cancer; 2003; 10(2):89-96. PubMed ID: 12736560
[TBL] [Abstract][Full Text] [Related]
10. Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?
Lewis-Wambi JS; Jordan VC
Breast Cancer Res; 2009; 11(3):206. PubMed ID: 19519952
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of estrogen receptor rapid responses to xenoestrogens: Physiological outcomes.
Marino M; Pellegrini M; La Rosa P; Acconcia F
Steroids; 2012 Aug; 77(10):910-7. PubMed ID: 22410438
[TBL] [Abstract][Full Text] [Related]
12. Estrogen signaling: a subtle balance between ER alpha and ER beta.
Matthews J; Gustafsson JA
Mol Interv; 2003 Aug; 3(5):281-92. PubMed ID: 14993442
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
[TBL] [Abstract][Full Text] [Related]
14. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.
Shan P; Tang B; Xie S; Zhang Z; Fan J; Wei Z; Song C
J Cell Biochem; 2021 Jan; 122(1):3-15. PubMed ID: 32985706
[TBL] [Abstract][Full Text] [Related]
15. [Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer].
Hanstein B; Beckmann MW; Bender HG
Zentralbl Gynakol; 2002 Jan; 124(1):17-9. PubMed ID: 11873309
[TBL] [Abstract][Full Text] [Related]
16. Steroidal aromatase inhibitors inhibit growth of hormone-dependent breast cancer cells by inducing cell cycle arrest and apoptosis.
Amaral C; Varela C; Borges M; Tavares da Silva E; Roleira FMF; Correia-da-Silva G; Teixeira N
Apoptosis; 2013 Nov; 18(11):1426-1436. PubMed ID: 23842740
[TBL] [Abstract][Full Text] [Related]
17. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
[TBL] [Abstract][Full Text] [Related]
18. Immune-Specific Expression and Estrogenic Regulation of the Four Estrogen Receptor Isoforms in Female Rainbow Trout (Oncorhynchus mykiss).
Casanova-Nakayama A; Wernicke von Siebenthal E; Kropf C; Oldenberg E; Segner H
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561790
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of estrogen receptor alpha function by antisense oligodeoxyribonucleotides.
Taylor AH; Pringle JH; Bell SC; Al-Azzawi F
Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):219-31. PubMed ID: 11572599
[TBL] [Abstract][Full Text] [Related]
20. The p53-estrogen receptor loop in cancer.
Berger C; Qian Y; Chen X
Curr Mol Med; 2013 Sep; 13(8):1229-40. PubMed ID: 23865427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
